IntraBio’s AQNEURSA® Gains CHMP Recommendation for Niemann-Pick Disease Type C, Signaling Major Breakthrough in Rare Neurological Disorder Treatment In a landmark development for the rare disease community, IntraBio Inc., a pioneering biopharmaceutical company specializing in therapies for rare and debilitating…
Compass Pathways Appoints Biopharmaceutical Veteran Justin Gover to Board of Directors as Company Advances Toward Potential Regulatory Milestone Compass Pathways plc (Nasdaq: CMPS), a biotechnology company at the forefront of developing innovative mental health treatments, announced today the appointment of…
LEO Pharma Achieves Landmark FDA Approval for ANZUPGO® (Delgocitinib) Cream to Treat Chronic Hand Eczema in U.S. Adults LEO Pharma, a global leader in medical dermatology with a deep-rooted focus on treating serious skin diseases, has announced that the U.S.…
Huonslab Strengthens HYDIZYME™ Pipeline with Formulation Patent, Targeting 2026 Market Launch Huonslab Co., Ltd., a subsidiary of Huons Global (KOSDAQ:084110), has taken a major step forward in its mission to bring innovative biologic formulations to market with the announcement that…
Charles River Teams Up with Elly’s Team to Accelerate Gene Therapy for Ultra-Rare NEDAMSS Disorder Charles River Laboratories International, Inc. (NYSE: CRL), a global leader in early-stage drug development and manufacturing services, has announced a collaborative agreement with Elly’s Team,…
Bristol Myers Squibb’s Sotyktu Makes Global Regulatory Progress for Psoriatic Arthritis as FDA Accepts sNDA for Review In a major development for immunology-focused therapeutics, Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has…
Genentech Receives FDA Complete Response Letter for Columvi Combination Therapy in Second-Line Diffuse Large B-Cell Lymphoma; Reaffirms Commitment to Advancing Columvi Across the Treatment Landscape Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the…
Fresenius Kabi Honored with 2025 Premier Supplier Legacy Award for Continued Excellence in Healthcare Delivery Fresenius Kabi, a leading global healthcare company specializing in lifesaving medicines and technologies, has once again been recognized for its longstanding commitment to excellence in…
BioNTech’s Chief Strategy Officer Ryan Richardson to Step Down After Pivotal Seven-Year Tenure BioNTech SE (Nasdaq: BNTX), the German-based global biotechnology company known for its groundbreaking work in mRNA technology and immunotherapies, has announced that Ryan Richardson, its Chief Strategy…
Thermo Fisher and Sanofi Expand Strategic Partnership with U.S. Sterile Manufacturing Deal Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in scientific services, has announced a significant expansion of its strategic collaboration with French biopharmaceutical giant Sanofi. This move…
Tempus Secures FDA 510(k) Clearance for AI-Driven ECG-Low EF Software, Expanding Capabilities in Cardiovascular Risk Detection Tempus AI, Inc. (NASDAQ: TEM), a trailblazer in applying artificial intelligence to drive precision medicine forward, has reached a significant milestone in the cardiology…
Satellos Bioscience Names Renowned Neuromuscular Expert Dr. Wildon Farwell as Chief Medical Officer to Advance Duchenne Therapy Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF), a biotechnology company pioneering small molecule therapies to treat muscle diseases, has appointed Dr. Wildon Farwell,…